Open Orphan’s hVIVO to manufacture a SARS-CoV-2 challenge virus
LONDON: hVIVO, a subsidiary of Open Orphan plc (LON: ORPH), has signed a contract with Imperial College London, as part of a Wellcome Trust funded initiative to manufacture a SARS-CoV-2 challenge virus. The contract is worth £3 million and under…